Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome
Authors:
- Justin StebbingJSJustin Stebbing
- Mark AtkinsMAMark Atkins
- Mark NelsonMNMark Nelson
- Shefali RajpopatSRShefali Rajpopat
- Tom Newsom-DavisTNTom Newsom-Davis
- Brian GazzardBGBrian Gazzard
- Mark BowerMBMark Bower
Open Access
- 15 March 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (6) , 2431-2432
Abstract
Here, patients with biopsy-proven systemic AIDS-related lymphoma (ARL) who received combination cytotoxic chemotherapy with curative intent were identified from a cohort of 5832 HIV-1–positive individuals followed up in the highly active antiretroviral therapy (HAART) era, commenced in 1996 (when HAART became freely available to our patients). HBV core (total) antibodies and the presence of HBV surface antigen were detected on stored sequential samples from these patients using the Axsym system (Abbott Laboratories, Chicago, IL). In those individuals who tested positive for HBV core antibodies and were surface-antigen negative, detection and quantification of HBV DNA were performed using real-time polymerase chain reactions (RealArt HBV RG PCR; Artus, Hamburg, Germany). Patient samples were obtained before, during, and following cytotoxic chemotherapy to be examined for evidence of chemotherapy-induced HBV reactivation. All patients were from the Chelsea and Westminster Hospital, one of the largest HIV cohorts in Europe, and the study received appropriate ethical approval.Keywords
This publication has 10 references indexed in Scilit:
- Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatmentThe Lancet Oncology, 2003
- Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective studyJournal of Medical Virology, 2003
- Steroid–Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv–Carriers With LymphomaHepatology, 2003
- A review of the case for hepatitis B vaccination of high-risk adultsThe American Journal of Medicine, 2003
- Sequelae and Serologic Outcome in Persons with Hepatitis B Virus InfectionAnnals of Internal Medicine, 2002
- Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issueThe Lancet Oncology, 2002
- Hepatitis B virus reactivation during cytotoxic chemotherapy‐enhanced viral replication precedes overt hepatitisJournal of Medical Virology, 2001
- Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factorsJournal of Medical Virology, 2000
- Serology of acute exacerbation in chronic hepatitis B virus infectionGastroenterology, 1993
- Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapyGastroenterology, 1991